This novel construct exhibited enhanced efficiency in systemic gene delivery for BBB traversal in mice and non-human primates, with a focus on delivering anti-cancer drugs such as PD-L1 or Herpes simplex virus 1 thymidine kinase (HSV-TK1) to GBM cells. Here, TK1 is linked to glioblastoma.